Medicare and Diabetes in Houston 2026: $35 Insulin Cap, Part D Coverage, and Where to Fill Your Rx

If you live in Houston and you have diabetes, the Medicare program in 2026 looks meaningfully different than it did three years ago. A covered insulin prescription costs no more than $35 a month — every month, no deductible required, regardless of which plan you are on. Total Part D out-of-pocket spending is capped at $2,100 a year. Continuous glucose monitors are covered under Part B for both Type 1 and Type 2 diabetics on insulin. And once you hit the Part D cap, your covered drugs cost $0 for the rest of the calendar year. For a Houston senior managing diabetes alongside two or three other chronic conditions, the math has changed in your favor.

This guide walks through what Medicare covers in 2026 for diabetes care for Harris County beneficiaries — insulin, oral medications, test strips, continuous glucose monitors, insulin pumps, diabetes self-management training, medical nutrition therapy, foot care, and eye exams — and where to fill prescriptions and find in-network specialists across the Houston metro. Every dollar figure and rule cited here is sourced from Medicare.gov, the CMS IRA Implementation pages, or the CDC’s diabetes surveillance data.

Diabetes in Houston: who is on Medicare with it

Diabetes is one of the most common chronic conditions among Medicare beneficiaries in Harris County. The CDC’s PLACES dataset estimates the adult diabetes prevalence in Houston city limits at roughly 13–15%, and significantly higher in some Harris County ZIPs — the East End, Pasadena, Aldine, and stretches of north and southeast Houston run above the metro average, often 17% or more. Among the Medicare-aged population (65+) the prevalence is meaningfully higher again, because the underlying biology of Type 2 diabetes is age-correlated.

That means in any given Harris County Medicare cohort, a significant minority — sometimes a plurality — has diabetes as a primary or secondary condition. Houston’s healthcare infrastructure reflects this. Endocrinology departments at Houston Methodist, Memorial Hermann, Baylor College of Medicine, and UT Physicians see thousands of Medicare-aged diabetics annually. Harris Health System — the safety-net public health system serving uninsured and underinsured Houstonians — runs one of the largest diabetes clinic networks in Texas at LBJ Hospital, Ben Taub, and a string of community clinics across the county. Even before any specific plan choice, Medicare itself is the financing layer underneath most of that care.

The $35 insulin cap — exactly how it works in 2026

The $35-per-month insulin cap took effect on January 1, 2023 under the Inflation Reduction Act of 2022 and has remained in place every year since. The 2026 plan year continues the cap unchanged. Specifically:

• Covered Part D insulins cost no more than $35 for a one-month supply at any pharmacy in your plan’s network. The Part D deductible does not apply to insulin — your $35 cost-share starts the very first refill of the year.
• Covered Part B insulins (insulin used in a covered insulin pump or DME-administered insulin) also cost no more than $35 for a one-month supply.
• The cap is per insulin product. If you take a basal insulin (e.g., glargine) and a mealtime insulin (e.g., aspart), each is capped at $35, so your total monthly insulin cost is up to $70.
• The cap applies only to covered insulins. Each plan’s formulary lists which insulin products it covers — typically the major brands and any biosimilars approved at that tier. If your specific brand is not on the formulary, ask your prescriber whether a covered alternative is appropriate, or request a formulary exception from the plan.

Continuous glucose monitors and insulin pumps under Part B

Continuous glucose monitors and insulin pumps are covered under Medicare Part B (not Part D) as durable medical equipment. Coverage rules:

• CGM eligibility requires a diagnosis of diabetes, intensive insulin therapy (or recent severe hypoglycemia), and a prescription from a treating clinician. Medicare covers CGMs for both Type 1 and Type 2 diabetics meeting the criteria. Common covered CGM systems in 2026 include Dexcom G7, Abbott FreeStyle Libre 2/3, and similar.
• Insulin pump eligibility requires a diagnosis of diabetes (most often Type 1 but also Type 2 in selected cases), a documented insulin regimen, and physician certification of medical necessity.
• Cost share after the Part B deductible is 20% coinsurance. Medigap policies with Part B coinsurance coverage (Plan G, Plan F for those grandfathered in, or High-Deductible Plan G) eliminate that 20% out-of-pocket. Medicare Advantage plans typically include their own DME cost-sharing structure, which varies.
• Insulin used in a covered pump is billed under Part B and capped at $35 per monthly supply.

For Houston diabetics on insulin who are not yet using a CGM, the Part B benefit is one of the most underused features of Medicare. The clinical case for CGMs in older adults has only strengthened — multiple studies show meaningful A1c improvement and hypoglycemia reduction. A 20-minute conversation with your endocrinologist or primary care physician about whether you qualify is usually the only step between paying out of pocket and having Medicare cover the device.

Oral diabetes medications under Part D in 2026

Oral diabetes drugs — metformin, glipizide, glimepiride, sitagliptin, empagliflozin, dapagliflozin, semaglutide oral, and others — are covered under your Medicare Part D plan (or the drug side of an MA-PD). 2026 brings several Part D changes that meaningfully affect diabetics:

• $2,100 annual out-of-pocket cap. Part D had no cap until 2025. The 2026 cap (the inflation-indexed step up from the 2025 baseline of $2,000) is the ceiling on what you pay across all your covered Part D drugs combined. Once you reach it, you pay $0 the rest of the calendar year.
• The donut hole is gone. Part D now runs in three phases — deductible, initial coverage (25% cost-share), and catastrophic ($0). The old four-phase design with a coverage gap is history.
• Medicare Drug Price Negotiation. The first ten drugs with CMS-negotiated maximum fair prices took effect January 1, 2026. Several diabetes-relevant drugs are on the initial list — Empagliflozin (Jardiance), Sitagliptin (Januvia), Insulin Aspart (NovoLog) among them. If you take any of those, your Part D plan’s negotiated price for the drug is bound by the federal ceiling, which usually flows through to lower copays in 2026.
• Medicare Prescription Payment Plan (M3P). Spreads your annual Part D out-of-pocket spend across monthly installments instead of a big spike at the pharmacy counter in February. Voluntary; opt in through your plan.

Diabetes Self-Management Training and Medical Nutrition Therapy

Two diabetes-specific Medicare benefits get used by far less than the eligible population. Both are worth knowing about.

Diabetes Self-Management Training (DSMT)

Medicare covers up to 10 hours of initial DSMT in the first 12 months after a diabetes diagnosis or new prescribing event, plus 2 hours of follow-up training each subsequent calendar year. Training is delivered by an accredited diabetes program — including programs at Houston Methodist, Memorial Hermann, Harris Health, and Baylor — and is covered under Part B. After meeting the Part B deductible, you pay 20% coinsurance (Medigap can fully cover that 20%). Medicare Advantage plans must cover at least the equivalent benefit; some are more generous.

DSMT is structured education on glucose monitoring, medication management, nutrition planning, exercise integration, complication prevention, and stress and behavior change. For newly diagnosed Houston seniors, it shortens the learning curve and reduces the rate of preventable hypoglycemia and hyperglycemia events. Ask your primary care physician for a referral.

Medical Nutrition Therapy (MNT)

Medicare also covers Medical Nutrition Therapy — counseling with a Registered Dietitian — for diabetics with a physician’s referral. The benefit is 3 hours initial in year one and 2 hours of follow-up in subsequent years, with additional hours allowed if the physician documents a clinical need. Under Original Medicare, MNT for diabetes is covered with no out-of-pocket cost to the beneficiary (no deductible, no coinsurance) when delivered by a Medicare-enrolled RD. Medicare Advantage plans are required to provide an equivalent benefit.

Annual eye exams, foot care, and A1c testing

Medicare Advantage plans must cover at least the equivalent of these benefits, usually with their own copay schedule (for example, $0 for an A1c lab, $0 to $40 for a podiatry visit, $0 to $50 for a retinal exam). Cost-sharing varies, so check the Evidence of Coverage document for your specific plan.

For Houston diabetics paying coinsurance on the Part B side, a Medicare Supplement (Medigap) plan — particularly Plan G — eliminates the 20% coinsurance for podiatry visits, retinal exams, DME, CGM supplies, and DSMT sessions. Whether that math is favorable for you depends on your overall utilization and the Medigap monthly premium versus an MA plan with bundled $0-copay diabetes care. A licensed agent can run the comparison in 20 minutes.

Where Houston diabetics fill prescriptions

Pharmacy networks matter for cost-sharing — the difference between a “preferred” and “standard” network pharmacy on a Part D or MA-PD plan can change your monthly insulin cap copay (the $35 ceiling holds either way), but it changes copays on your other diabetes drugs significantly. The major pharmacy chains operating across Houston are:

• H-E-B Pharmacy — H-E-B is in most Part D and MA-PD networks in Harris County, often at the preferred tier.
• Kroger Pharmacy — broad network presence, often preferred-tier on multiple major plans.
• CVS Pharmacy — preferred tier on several MA-PD plans, especially CVS-affiliated drug-side benefits (Aetna, SilverScript).
• Walgreens — wide Houston network, varies plan-by-plan whether preferred or standard.
• Walmart Pharmacy — preferred-tier on certain low-premium PDPs; verify each year.
• Costco Pharmacy — Houston has multiple locations; competitive pricing on generics.
• Independent pharmacies — many serve specific neighborhoods (Bellaire, Spring Branch, the East End) and may be in-network even if not preferred.
• Mail-order pharmacy — most plans offer 90-day mail-order at preferred-tier cost-sharing for ongoing diabetes medications. Often the lowest-cost option for stable regimens.

If you have a longstanding pharmacist relationship — common in Houston’s Vietnamese, Indian, and Hispanic communities, where independent pharmacies often double as health-information hubs — preserve that relationship by checking each year that the independent is still in-network on your plan. Independent pharmacies sometimes get dropped from preferred tiers when chains negotiate exclusive arrangements with insurers.

2026 diabetes coverage at a glance

How to pick a Medicare plan that actually fits diabetes

The Houston-area diabetic on Medicare has three meaningful structural choices to make:

1. Original Medicare + Medigap + stand-alone Part D

Best for diabetics who use multiple Houston-area health systems, want maximum specialist flexibility, and either travel a lot or split time between Houston and another city/state. Medigap (especially Plan G) covers the 20% Part B coinsurance on CGMs, insulin pump supplies, podiatry, retinal exams, and DSMT. Combined with a stand-alone Part D plan that covers your specific oral diabetes drugs and insulin, this is the most comprehensive but also the highest-monthly-premium option. See our High Deductible Medigap Plans page for a lower-premium variant.

2. Medicare Advantage Prescription Drug (MA-PD)

Best for diabetics who use a single Houston health system (Houston Methodist, Memorial Hermann, HCA Houston, Harris Health) and want bundled drug + medical coverage with a low monthly premium. Many MA-PD plans in Harris County include $0 primary care, $0 podiatry, $0 retinal exam, and bundled OTC allowances that can offset diabetes-related supply costs. The trade-off: tighter network and prior authorization for some specialty care. See our Medicare Advantage Plans page for an overview.

3. Chronic-Condition Special-Needs Plan (C-SNP)

Some Harris County carriers offer a diabetes-specific C-SNP — a Medicare Advantage variant with a tighter formulary, condition-aligned care management, and supplemental benefits (e.g., enhanced foot-care, OTC diabetic supply allowances) targeted at diabetics. Eligibility requires a documented diabetes diagnosis. Whether a C-SNP beats a regular MA-PD for your specific situation depends on your specialist mix and your medication list. Compare both before enrolling.

For more on the broader plan landscape, see our Medicare Plans overview, Medicare Eligibility page, and Medicare hub.

Frequently asked questions

Kim Nguyen is a licensed insurance agent in Texas. The content here is general guidance and not a substitute for medical advice. Diabetes care decisions should be made with your treating clinician. Plan-specific drug coverage, formulary tiers, and pharmacy network status change annually — verify with your Part D or MA-PD plan before any election.